Effects of dexmedetomidine in adult patients with agitated delirium in palliative care: an open-label phase I/II proof-of-concept, dose-finding, and feasibility clinical trial
Identifying Genetic Factors Impacting Opioid Response in the Advance Cancer Palliative Care Population